Talking Trials, Investment And Fluid-Overload Treatments With Sequana Medical

 
• By Barnaby Pickering

Sequana Medical is simultaneously developing both drug and device treatments for fluid overloads in the body. Medtech Insight spoke to the company’s CEO about their trials and the challenges of raising cash in 2023.

Sequana Medical's products are looking to address failures of homeostasis' control on water and salt content in the body
Sequana Medical's products are looking to address failures of homeostasis' control on water and salt content in the body • Source: Shutterstock

More from Clinical Trials

More from R&D